Nichols & Pratt Advisers LLP Abbott Laboratories Transaction History

Nichols & Pratt Advisers LLP

$1.4 Billion
Q1 2025

A detailed history of Nichols & Pratt Advisers LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 33,727 shares of ABT stock, worth $4.52 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

33,727

Previous 35,927 6.12%

Holding current value

$4.52 Million

Previous $4.06 Million 10.09%

% of portfolio

0.32%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$111.1 - $140.22 $244,420 - $308,484	-2,200 Reduced 6.12%	33,727 $4.47 Million
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $63,544 - $75,012	-635 Reduced 1.74%	35,927 $4.1 Million
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $30,219 - $33,732	-300 Reduced 0.81%	36,562 $3.8 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $58,483 - $64,592	-534 Reduced 1.43%	36,862 $4.19 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $194,630 - $238,243	-2,158 Reduced 5.46%	37,396 $4.12 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $28,659 - $34,386	300 Added 0.76%	39,554 $3.83 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $98,260 - $109,482	-975 Reduced 2.42%	39,254 $4.28 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $326,902 - $384,783	3,375 Added 9.16%	40,229 $4.07 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $43,442 - $50,964	457 Added 1.26%	36,854 $4.05 Million
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $557,337 - $645,292	-5,760 Reduced 13.66%	36,397 $3.52 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $67,162 - $81,177	658 Added 1.59%	42,157 $4.58 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $17,103 - $20,856	-150 Reduced 0.36%	41,499 $4.91 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $9,820 - $12,024	85 Added 0.2%	41,649 $5.86 Million
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $1,166 - $1,290	-10 Reduced 0.02%	41,564 $4.87 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $52,895 - $62,265	500 Added 1.22%	41,574 $4.82 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $29,386 - $34,622	-270 Reduced 0.65%	41,074 $4.92 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $259,350 - $282,617	-2,470 Reduced 5.64%	41,344 $4.53 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $27,492 - $33,387	300 Added 0.69%	43,814 $4.77 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $730,094 - $934,430	-9,535 Reduced 17.97%	43,514 $3.98 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $193,171 - $282,469	3,075 Added 6.15%	53,049 $4.19 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $720,957 - $802,594	-9,183 Reduced 15.52%	49,974 $4.34 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $96,898 - $105,068	-1,184 Reduced 1.96%	59,157 $4.95 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $19,240 - $22,440	-264 Reduced 0.44%	60,341 $5.08 Million
Q1 2019 Apr 30, 2019	BUY	$66.22 - $80.06 $1,258 - $1,521	19 Added 0.03%	60,605 $4.85 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $70,477 - $79,840	-1,075 Reduced 1.74%	60,586 $4.38 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $171,788 - $207,242	-2,825 Reduced 4.38%	61,661 $4.52 Million
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $20,149 - $22,239	350 Added 0.55%	64,486 $3.93 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $416,288 - $445,679	-7,755 Reduced 10.79%	64,136 $3.66 Million
Q3 2017 Nov 08, 2017	SELL	$48.06 - $53.64 $14,418 - $16,092	-300 Reduced 0.42%	71,891 $3.84 Million
Q2 2017 Aug 08, 2017	BUY	N/A	72,191	72,191 $3.51 Million

Others Institutions Holding ABT

# of Institutions

3,542

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $235B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Account

Nichols & Pratt Advisers LLP Abbott Laboratories Transaction History